Clinical benefit with PEMAZYRE — 3 of 3

Responses with PEMAZYRE are durable

Durable benefits were observed with PEMAZYRE (N=108), with a median duration of response of 8.1 months1

Median DOR was 8.1 months
(95% CI, 5.65–13.14)1*

8.1

Months

*95% CI was calculated using the Brookmeyer and Crowley method.1

57.7%

(n=23)

Patients with response maintained for ≥6 months27

37.5%

(n=15)

Patients with response maintained for ≥9 months27

25.0%

(n=10)

Patients with response maintained for ≥12 months27

For further efficacy information, please refer to the PEMAZYRE Summary of Product Characteristics.1